United States $1 Billion Non-Invasive Prenatal Testing (NIPT) Market Insights, Opportunity Analysis & Growth Potential 2017-2023

Dublin, Aug. 16, 2017 -- The "United States Non-Invasive Prenatal Testing (NIPT) Market Insights, Opportunity, Analysis, Growth Potential & Demand Forecast 2017-2023" report has been added to Research and Markets' offering.

The research report titled United States Non-Invasive Prenatal Testing(NIPT) Market Insights, Opportunity, Analysis, Growth Potential & Demand Forecast 2017 - 2023 examines the market, competitive landscape and trends of the United States NIPT Test Market. The study provides an in-depth analysis of the actual and potential NIPT test market.

Market growth can be attributed to factors such as rapid penetration of high and average risk NIPT test, high incidence rate of babies born with down syndrome, no risk of miscarriage with NIPT, shifting trend towards child bearing at advanced maternal age (35 years or older), launch of new and advanced NIPT products. With increased patient access to NIPT test, United States NIPT test market is anticipated to have a positive outlook in the coming years.

The report provides a decisive view on the NIPT Test volume and market in United States. It also covers reimbursement pattern and offers a clear view of the regulatory landscape in the United States NIPT Test Market. Additionally, the report includes insights into the NIPT implementation in the high-income countries. Key trends in terms of collaboration, partnership, merger & acquisition, venture capital investment distribution and licensing agreement are analyzed with details. The report also explores detailed description of growth drivers and inhibitors of the United States NIPT Test Market.

The report concludes with the profiles of major players in the United States NIPT Test Market. The key market players are evaluated on various parameters such as company overview, NIPT test portfolio, NIPT test analysis with volume and market revenue and latest development and trends of the NIPT Test Market.

Key Topics Covered in the Report:

• United States Actual NIPT Test Volume & Market Revenue (2015 - 2023)
• United States Potential NIPT Test Volume & Market Revenue (2015 - 2023)
• United States Average Risk Actual NIPT Test Volume & Market Revenue (2015 - 2023)
• United States Average Risk Potential NIPT Test Volume & Market Revenue (2015 - 2023)
• United States High Risk Actual NIPT Test Volume & Market Revenue (2015 - 2023)
• United States High Risk Potential NIPT Test Volume & Market Revenue (2015 - 2023)
• United States NIPT Test Market - Reimbursement & Regulation System
• NIPT Test Implementation in High-Income Countries
• United States NIPT Test Market - Comparative Test Analysis
• United States NIPT Test Market - Major Deal Types
• Key Companies Analysis
• Key Drivers and Inhibitors of the United States NIPT Test Market

Key Companies Covered in the Report are as follows:

• Sequenom Laboratories (LabCorp)
• Ariosa Diagnostics (Roche)
• Illumina
• Natera
• Quest Diagnostics

Key Topics Covered:

1. Executive Summary

2. United States Non-Invasive Prenatal Testing(NIPT) Market Analysis (2015 - 2023)
2.1 Overall Actual NIPT Test Volume & Forecast
2.1.1 Average Risk Actual NIPT Test Volume & Forecast
2.1.2 High Risk Actual NIPT Test Volume & Forecast
2.2 Overall Potential NIPT Test Volume & Forecast
2.2.1 Average Risk Potential NIPT Test Volume & Forecast
2.2.2 High Risk Potential NIPT Test Volume & Forecast
2.3 Overall Actual NIPT Test Market Revenue & Forecast
2.3.1 Average Risk Actual NIPT Test Market Revenue & Forecast
2.3.2 High Risk Actual NIPT Test Market Revenue & Forecast
2.4 Overall Potential NIPT Test Market Revenue & Forecast
2.4.1 Average Risk Potential NIPT Test Market Revenue & Forecast
2.4.2 High Risk Potential NIPT Test Market Revenue & Forecast

3. Key Drivers and Inhibitors of the United States NIPT Test Market
3.1 Market Drivers
3.2 Inhibitors

4. United States NIPT Test Market: Reimbursement & Regulation System
4.1 Reimbursement System
4.2 Regulation System

5. Non-Invasive Prenatal Testing (NIPT) Implementation - High-Income Countries
5.1.1 Clinical Issues
5.1.2 Ethical Issues
5.1.3 Legal and Regulatory Issues

6. Competitive Landscape
6.1 Non-Invasive Prenatal Testing(NIPT) - Comparative Analysis
6.2 Non-Invasive Prenatal Testing - Collaboration Deals
6.2.1 Year 2007
6.2.2 Year 2013
6.2.3 Year 2014
6.2.4 Year 2015
6.2.5 Year 2016
6.2.6 Year 2017
6.3 Non-Invasive Prenatal Testing - Venture Capital Investment
6.3.1 Year 2011
6.3.2 Year 2012
6.3.3 Year 2013
6.3.4 Year 2015
6.4 Non-Invasive Prenatal Testing - Merger and Acquisition
6.4.1 Year 2013
6.4.2 Year 2014
6.4.3 Year 2016
6.5 Non-Invasive Prenatal Testing - Exclusive Agreement
6.5.1 Year 2008
6.5.2 Year 2013
6.5.3 Year 2014
6.5.4 Year 2015
6.5.5 Year 2016
6.6 Non-Invasive Prenatal Testing - Licensing Agreement
6.6.1 Year 2007
6.6.2 Year 2011
6.6.3 Year 2013
6.6.4 Year 2014
6.6.5 Year 2015
6.7 Non-Invasive Prenatal Testing - Distribution Agreement
6.7.1 Year 2012
6.7.2 Year 2013
6.7.3 Year 2014
6.8 Non-Invasive Prenatal Testing - Partnership Deals
6.8.1 Year 2013
6.8.2 Year 2014
6.8.3 Year 2015

7. Key Companies Analysis
7.1 Sequenom Laboratories (LabCorp)
7.2 Ariosa Diagnostics (Roche)
7.3 Illumina
7.4 Natera
7.5 Quest Diagnostics

For more information about this report visit https://www.researchandmarkets.com/research/rs5hxj/united_states

CONTACT: Research and Markets
         Laura Wood, Senior Manager
         [email protected]
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
         U.S. Fax: 646-607-1907
         Fax (outside U.S.): +353-1-481-1716
         Related Topics: Diagnostics, Women's Health